ReplyLetter
Reply:
Tshea Dowers and Paula Alcaide-Leon
American Journal of Neuroradiology October 2024, DOI: https://doi.org/10.3174/ajnr.A8538
Tshea Dowers
Department of Medical ImagingUniversity of TorontoToronto, Ontario, Canada
Paula Alcaide-Leon
Department of Medical ImagingUniversity of TorontoToronto, Ontario, Canada

References
- 1.↵Product Monograph Including Patient Medication Information Gadovist® 1.0 Gadobutrol Injection (Solution, 604 Mg/mL (1.0 Mmol/mL) for Intravenous Use) Contrast Enhancement Agent for Magnetic Resonance Imaging (MRI). Bayer Inc, June 24, 2024. https://www.bayer.com/sites/default/files/2020-11/gadovist-pm-en-0.pdf. Accessed September 29, 2024
- 2.↵
- Boto J,
- Guatta R,
- Fitsiori A, et al
Advertisement
Tshea Dowers, Paula Alcaide-Leon
Reply:
American Journal of Neuroradiology Oct 2024, DOI: 10.3174/ajnr.A8538
0 Responses
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement